The Center for Data Innovation spoke with Bill Shipman, co-founder and chief technology officer of Polaris Quantum Biotech, a North Carolina-based company that uses quantum computing to help discover and design new drugs. Shipman discussed how Polaris’ platform accelerates drug discovery, what advantages quantum offers for this field, and how future advances in scaling the computational power of quantum hardware will impact the company.

Read more here.